Nephrology Stents And Catheters Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 7.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Nephrology Stents And Catheters Market Analysis
The nephrology stents and catheters market is valued at USD 1.44 billion in 2023 and is expected to reach USD 2.03 billion by the year 2028, registering a CAGR of 7.10% over the forecast period.
COVID-19 impacted the growth of the nephrology stents and catheter market. The lockdown measures imposed by the government to avoid the spread of coronavirus among the population resulted in the shutting down of patient visits in hospitals, clinics, and dialysis centers, which has impacted the lives of patients suffering from nephrology diseases. For instance, from an article published in Frontiers in Physiology in July 2021, it has been observed that the diagnosis of various kidney diseases was delayed during the COVID-19 pandemic as non-urgent tests and visits were postponed due to the closure of medical services during the lockdown. This has affected the histological examination for kidney diagnosis in the initial days of the pandemic, impacting the demand for nephrology stents and catheters during the pandemic. However, in later times of the pandemic, with the resumption of non-essential surgical procedures, the market has started to gain traction. It is expected to continue the upward trend over the forecast period.
The increasing incidence of nephrology disorders, rising geriatric population, and technological advancement in the material used for catheters and stents are the major drivers for the market. For instance, as per the data published by the Australian Institute of Health and Welfare in August 2022, it was observed that in Aboriginal and Torres Strait Islanders, 292 males and 677 females per 100,000 population had chronic kidney diseases in 2021, respectively. As per the same source, Indigenous Australians were 4.6 times more likely to be diagnosed with chronic kidney disease than their non-Indigenous counterparts. Thus, such instances indicate that the demand for surgeries is expected to increase, which may surge the demand for nephrology stents and catheters, thereby propelling the market growth.
The strong pipeline scenario related to nephrology stents and catheters drives market growth. For instance, according to the research journal published by the Medical Device Network in January 2022, pipeline nephrology and urology products in 2021 witnessed a 75.0% rise globally compared to Nephrology and Urology pipeline products in 2020. The devices at an advanced stage of development (in clinical trials, in the approval process, already approved in Europe, or in the rest of the world) accounted for 45.65% of medical devices in 2021, compared to 37.93% in 2020. The number of devices at the approval stage in 2021 increased by 100.0% compared to 2020. Furthermore, the same source also stated that approximately 43.0% of pipeline nephrology and urology devices in 2021 were expected to receive regulatory approval by the end of 2025. The top device category expected to receive regulatory approval by the end of 2025 was urinary catheters, with 6.0% of devices. Thus, owing to increasing regulatory approvals, the demand for nephrology stents and catheters is expected to increase; thereby, considerable market growth is expected over the forecast period.
However, discomfort and pain due to stents and catheters and the risk of infection due to unclean instruments will likely restrict the market growth over the forecast period.
Nephrology Stents And Catheters Market Trends
Balloon Catheters Segment is Expected to Witness Considerable Growth Over the Forecast Period
Balloon catheters are used in many minimally invasive diagnostic and therapeutic procedures, including dilating vessels, opening blockages, delivering stents, and more. The balloon catheter dilates the musculofascial tract and renal capsule, establishing a nephrostomy tract during a percutaneous procedure.
The advantages of the balloon catheter and increasing chronic kidney disease cases are the segment's major drivers. For instance, as per the 2022 statistics published by CDC, the prevalence of CKD is higher in people aged 65 years or older than in people aged between 45-64 years or 18-44 years. Similarly, according to the 2022 statistics published by UNPF, about 24.0% and 19.0% of people in Italy and Canada are aged 65 years or above, respectively. This is anticipated to increase the risk of these populations developing CKD. Hence augmenting the segment growth.
Furthermore, the rising government initiative for spreading awareness regarding CKD and early diagnosis also contributes to the market growth. For instance, the CDC Chronic Kidney Disease (CKD) Initiative focuses on a comprehensive public health strategy involving other public health agencies and national organizations to address CKD. This program supports activities such as disease surveillance, assists in increasing knowledge of CKD and its complications, encourages early detection and treatment, and enhances the quality of life for those with CKD. Similarly, the Kidney Failure Probability Equation (KFRE) is a simple and extensively used method for predicting kidney failure risk among CKD patients. In addition, innovative product launches by the key players are also propelling market growth. For instance, in March 2022, Nipro Medical Corporation (Nipro) launched a second-generation Cronus HP PTA Balloon Catheter in the United States. Cronus HP enables easy repair and restoration of arteriovenous fistulas and is considered the treatment gateway for hemodialysis patients. Thus, increasing cases of chronic kidney diseases and favorable initiatives across the globe are the major drivers for the segment.
North America Region is Expected to Witness Significant Growth Over the Forecast Period
North America is expected to witness a significant market share in the chronic kidney diseases market over the forecast period. The major factors driving the market growth are the rising prevalence of chronic kidney diseases, the presence of well-established healthcare infrastructure along with high health spending, and technologically advanced diagnostic tests. The increasing burden of chronic kidney diseases among the population is the key factor driving the market growth. For instance, per the report published by the American Kidney Fund in February 2022, an estimated 37.0 million Americans have kidney disease, and 92,000 are on the kidney transplant waiting list (as of February 2022). Thus, owing to increasing cases of diseases in the North American region, considerable market growth is expected over the forecast period.
Key product launches, high concentration of market players or manufacturer's presence, acquisition & partnerships among major players, increasing prevalence of diseases, and well-established healthcare expenditure in the United States are some of the factors driving the growth of the country's nephrology stents and catheters market. For instance, per the 2022 statistics published by the American Cancer Society, about 79,000 new cases of kidney cancer (50,290 in men and 28,710 in women) are expected to be diagnosed in the United States in 2022. As per the same source, the lifetime risk of developing kidney cancer is higher in men (2.02%) than in women (1.03%). Similarly, according to the OECD, in June 2022, United States healthcare spending in 2021 was 17.8% of the country's total GDP. In addition, as per the CMS, the National Health Expenditure (NHE) is projected to grow at an average of 5.1% over 2021-2030 and to reach USD 6.8 trillion by 2030. As NHE is projected to grow 1.1% points faster than gross domestic product per year on average over 2021-2030, the health share of the economy is projected to rise by 19.6% in 2030. Thus, such instances are expected to propel the market growth in the country over the forecast period.
Nephrology Stents And Catheters Industry Overview
The nephrology stents and catheters market is moderately fragmented due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few well-known international and local companies with significant market shares: Angiodynamics Inc., Rocamed, Ameco Medical Industries, Boston Scientific Corporation, and Teleflex Incorporated, among others.
Nephrology Stents And Catheters Market Leaders
-
AngioDynamics
-
Boston Scientific Corporation
-
Teleflex Incorporated
-
Cardinal Health Inc
-
Becton, Dickinson and Company
*Disclaimer: Major Players sorted in no particular order
Nephrology Stents And Catheters Market News
- August 2022: Otsuka Pharmaceutical Factory, Inc. launched an intermittent urological catheter OT-Balloon Catheter. This product is a reusable catheter, and it offers self-catheterization for people having difficulty in urinating spontaneously for various reasons.
- July 2022: Medtronic recalled 1.0 million Class I dialysis catheters at risk of leaking. According to the FDA's recall database, the recall covered 1,019,414 hemodialysis catheters manufactured by Medtronic subsidiary Covidien. It spanned several models of nine separate catheters marketed under the device maker's Palindrome and Mahurkar product names. More than half of the affected devices are labeled as Palindrome Chronic Catheters.
Nephrology Stents & Catheters Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Nephrology Disorders
4.2.2 Increasing Geriatric Population
4.2.3 Technological Advancement in the Material Used for Catheters and Stents
4.3 Market Restraints
4.3.1 Discomfort and Pain due to Stents and Catheters
4.3.2 Risk of Infection due to Unclean Instruments
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Product
5.1.1 Nephrology Catheters
5.1.1.1 Balloon Catheters
5.1.1.2 Malecot Catheters
5.1.1.3 J Tip Catheters
5.1.1.4 Pigtail Catheters
5.1.2 Nephrology Stents
5.1.2.1 Metal Stents
5.1.2.2 Polymer Stents
5.2 By End-User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Specialty Clinics
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Angiodynamics Inc.
6.1.2 Rocamed
6.1.3 Ameco Medical Industries
6.1.4 Boston Scientific Corporation
6.1.5 UROMED
6.1.6 Teleflex Incorporated
6.1.7 Cardinal Health Inc
6.1.8 Envaste Limited
6.1.9 Merit Medical
6.1.10 Becton, Dickinson and Company
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Nephrology Stents And Catheters Industry Segmentation
As per the report's scope, the catheter is a thin tube made from medical-grade materials used to treat diseases or perform a surgical procedure. Renal artery stenting is a procedure to open the renal arteries when they have become blocked due to renal artery stenosis using nephrology stents. The Nephrology Stents and Catheters Market is Segmented by Product (Nephrology Catheters and Nephrology Stents), End-User (Hospital, Ambulatory Surgery Centers, and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Product | ||||||
| ||||||
|
| By End-User | |
| Hospitals | |
| Ambulatory Surgical Centers | |
| Specialty Clinics |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Nephrology Stents & Catheters Market Research FAQs
What is the current Nephrology Stents and Catheters Market size?
The Nephrology Stents and Catheters Market is projected to register a CAGR of 7.10% during the forecast period (2024-2029)
Who are the key players in Nephrology Stents and Catheters Market?
AngioDynamics, Boston Scientific Corporation, Teleflex Incorporated, Cardinal Health Inc and Becton, Dickinson and Company are the major companies operating in the Nephrology Stents and Catheters Market.
Which is the fastest growing region in Nephrology Stents and Catheters Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Nephrology Stents and Catheters Market?
In 2024, the North America accounts for the largest market share in Nephrology Stents and Catheters Market.
What years does this Nephrology Stents and Catheters Market cover?
The report covers the Nephrology Stents and Catheters Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nephrology Stents and Catheters Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Nephrology Stents and Catheters Industry Report
Statistics for the 2024 Nephrology Stents And Catheters market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Nephrology Stents And Catheters analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
